Pershing Square: No Wrongdoing In Allergan Bid - Presented by: The Aol. On Network

The hedge fund founded by activist investor William Ackman has denied wrongdoing amid reports that federal regulators are examining whether the fund and Valeant Pharmaceuticals VRX violated securities laws while pursuing a hostile takeover of Botox maker Allergan AGN . Pershing Square Capital Management said there was nothing improper in its accumulation of a 10% stake in California-based Allergan and support of Valeant's takeover bid.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.88 0.25 ▼ 1.38%
MU $ 18.51 1.39 ▼ 6.98%
FB $ 94.01 1.20 ▼ 1.26%
AAPL $ 121.30 1.07 ▼ 0.87%
SUNE $ 23.28 2.35 ▼ 9.17%
SUSQ $ 14.20 0.11 ▼ 0.77%
F $ 14.83 0.27 ▼ 1.79%
MSFT $ 46.70 0.18 ▼ 0.38%

As of 7/31/2015, 04:15 PM